{"title":"Macaque model of inherited macular dystrophy","authors":"Alexandra Le Bras","doi":"10.1038/s41684-025-01590-9","DOIUrl":null,"url":null,"abstract":"<p>Inherited macular dystrophies are a group of genetic disorders resulting in progressive damage to the cells in the macula, leading to vision loss. Although gene- and cell-based therapies offer promising approaches for these conditions, progress is hindered by the lack of animal models that recapitulate the macular changes observed in patients. In <i>JCI insight</i>, Xialin Liu’s team reports the first spontaneous nonhuman primate model of inherited macular dystrophy. Few years ago, while performing ocular biometric measurements in a cohort of <i>Macaca fascicularis</i> using advanced imaging techniques, the team identified a 6.8-year-old male with macular abnormalities. Whole-genome sequencing data revealed that the animal was carrying a <i>BEST1p.Q327E</i> variant. In humans, mutations in the <i>BEST1</i> gene give rise to Best vitelliform macular dystrophy (BVMD), one of the most common inherited macular dystrophies. Longitudinal imaging of the animal over two years revealed progressive macular changes, lipid-rich deposit accumulation, retinal pigment epithelium disruption and photoreceptor degeneration, recapitulating early human BVMD pathology. Histological analysis also indicated a buildup of damaged cone mitochondria. The model, which provides new insights into the pathophysiological processes involved in macular diseases, could be valuable for testing potential therapies.</p><p><b>Original reference:</b> Yi, W. et al. <i>JCI Insight</i> <b>10</b>, e190807 (2025)</p>","PeriodicalId":17936,"journal":{"name":"Lab Animal","volume":"26 1","pages":""},"PeriodicalIF":3.9000,"publicationDate":"2025-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Lab Animal","FirstCategoryId":"97","ListUrlMain":"https://doi.org/10.1038/s41684-025-01590-9","RegionNum":3,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"VETERINARY SCIENCES","Score":null,"Total":0}
引用次数: 0
Abstract
Inherited macular dystrophies are a group of genetic disorders resulting in progressive damage to the cells in the macula, leading to vision loss. Although gene- and cell-based therapies offer promising approaches for these conditions, progress is hindered by the lack of animal models that recapitulate the macular changes observed in patients. In JCI insight, Xialin Liu’s team reports the first spontaneous nonhuman primate model of inherited macular dystrophy. Few years ago, while performing ocular biometric measurements in a cohort of Macaca fascicularis using advanced imaging techniques, the team identified a 6.8-year-old male with macular abnormalities. Whole-genome sequencing data revealed that the animal was carrying a BEST1p.Q327E variant. In humans, mutations in the BEST1 gene give rise to Best vitelliform macular dystrophy (BVMD), one of the most common inherited macular dystrophies. Longitudinal imaging of the animal over two years revealed progressive macular changes, lipid-rich deposit accumulation, retinal pigment epithelium disruption and photoreceptor degeneration, recapitulating early human BVMD pathology. Histological analysis also indicated a buildup of damaged cone mitochondria. The model, which provides new insights into the pathophysiological processes involved in macular diseases, could be valuable for testing potential therapies.
Original reference: Yi, W. et al. JCI Insight10, e190807 (2025)
期刊介绍:
LabAnimal is a Nature Research journal dedicated to in vivo science and technology that improves our basic understanding and use of model organisms of human health and disease. In addition to basic research, methods and technologies, LabAnimal also covers important news, business and regulatory matters that impact the development and application of model organisms for preclinical research.
LabAnimal's focus is on innovative in vivo methods, research and technology covering a wide range of model organisms. Our broad scope ensures that the work we publish reaches the widest possible audience. LabAnimal provides a rigorous and fair peer review of manuscripts, high standards for copyediting and production, and efficient publication.